-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Artemis Therapeutics Inc. (OTCMKTS:ATMS) Sees Large Decrease in Short Interest
Artemis Therapeutics Inc. (OTCMKTS:ATMS) Sees Large Decrease in Short Interest
Artemis Therapeutics Inc. (OTCMKTS:ATMS – Get Rating) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 700 shares, a decline of 61.1% from the October 15th total of 1,800 shares. Based on an average daily trading volume, of 2,400 shares, the days-to-cover ratio is presently 0.3 days.
Artemis Therapeutics Stock Performance
Artemis Therapeutics stock opened at $1.40 on Friday. Artemis Therapeutics has a 1 year low of $0.55 and a 1 year high of $5.00. The business has a 50-day moving average of $1.96 and a 200-day moving average of $2.49.
Get Artemis Therapeutics alerts:Artemis Therapeutics Company Profile
(Get Rating)
Artemis Therapeutics Inc, a beauty company, develops and distributes skincare products in Israel. The company offers face serum with manuka honey and bee venom, face serum with enhanced vitamin C, day cream, night nourishing cream with manuka honey and nee venom, eye cream with manuka honey and bee venom, and face cleanser gel.Featured Articles
- Get a free copy of the StockNews.com research report on Artemis Therapeutics (ATMS)
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
Artemis Therapeutics Inc. (OTCMKTS:ATMS – Get Rating) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 700 shares, a decline of 61.1% from the October 15th total of 1,800 shares. Based on an average daily trading volume, of 2,400 shares, the days-to-cover ratio is presently 0.3 days.
Artemis治疗公司(场外交易代码:ATMS-GET Rating)在10月份看到空头股数的销售额大幅下降。截至10月31日,空头股数共有700股,较10月15日的1,800股下降了61.1%。以日均成交量2,400股计算,目前天数与回补比率为0.3天。
Artemis Therapeutics Stock Performance
Artemis治疗公司股票表现
Artemis Therapeutics stock opened at $1.40 on Friday. Artemis Therapeutics has a 1 year low of $0.55 and a 1 year high of $5.00. The business has a 50-day moving average of $1.96 and a 200-day moving average of $2.49.
Artemis治疗公司的股票周五开盘报1.40美元。Artemis Treeutics的一年低点为0.55美元,一年高位为5.00美元。该业务的50日移动均线切入位在1.96美元,200日移动均线切入位在2.49美元。
Artemis Therapeutics Company Profile
Artemis治疗公司简介
(Get Rating)
(获取评级)
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Artemis Therapeutics (ATMS)
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
- 免费获取StockNews.com关于Artemis治疗(ATMS)的研究报告
- 中盘Neurocrine生物科学是井喷后的第三季度报告吗?
- 六面旗帜是一种你不想被困住的旅程
- Hanesbrand可能发出零售类股本周表现不佳的信号
- 愿景氢,现在的愿景能源,将希望寄托在股票拆分上
- 优惠券股票和你为什么应该关心
Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接受Artemis治疗日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Artemis治疗公司和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧